Fig. 7
From: Steroid receptor coactivator-3 inhibition generates breast cancer antitumor immune microenvironment
SRC-3 KD changes the tumor-infiltrating immune cell repertoire in E0771 breast tumors. A-D Quantification of CD4 + T cells (A), CD8 + T cells (B), CD56 + NK cells (C), and Ifng (D) in SRC-3 KD E0771 versus control KD breast tumors in C57BL/6J mice, as determined by IHC with antibodies against their respective target proteins. Quantifications of the percentages of labeled cells (PLC) with CD4, CD8, CD56, and Ifng in SRC-3 KD E0771 versus control KD breast tumors are shown in the graph